09.19.25 -- Did Trump Just Create An Antibiotic Supply Chain In The US?

Discover how Cambrex is advancing peptide manufacturing with innovative liquid phase peptide synthesis (LPPS) technology, reducing costs, environmental impact, and reliance on specialized reactors. Join experts Adrian Amador and David Wang for this live webinar exploring LPPS applications, regulatory considerations, impurity control, and analytical strategies. Register today to gain insights that can accelerate your peptide development programs. Click here to learn more.

Developing flow-based manufacturing processes requires expertise in several disciplines, the ability to design and build custom reactors, and the scientific infrastructure to support production.

In response to an Open Letter regarding supplier targets from leading pharma companies, witness how CDMOs are adapting their SOPs to improve sustainability and reduce CO2 emissions.

In this survey, 200+ people involved in the oral dose market shared their views on barriers to the development of oral formulations and technological responses to them.

It is no longer sufficient to just meet compliance requirements; a proactive, risk-based approach to contamination control is now a differentiating factor that enhances operational efficiency and more. For biotech companies evaluating CDMOs, this shift is critical.

What if a formulation that removed the need for cold chain distribution was possible? Explore the formulation of vaccines and manufacturing considerations for dry powder inhaled vaccines.

Consider the pros and cons of marketed amorphous solid dispersions with so-far unpublished data, as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.

Liquid-filled, two-piece capsules offer significant advantages over traditional solid dosage forms. Here, we review the five reasons liquid-filled capsules (LFCs) can benefit your clinical trials.

Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.

Boost your drug development success with Lonza’s upcoming webinar on amorphous solid dispersions (ASDs). Learn how hot melt extrusion (HME) can enhance bioavailability, cut costs, and scale efficiently—backed by real-world lab and pilot trials. Compare HME and spray drying while gaining exclusive insights into Lonza’s advanced capabilities and proven expertise in ASD manufacturing. Don't miss it! Click here to learn more.

Assuring GMP Quality and Regulatory Compliance throughout your supply chain is a challenge. Meeting this challenge requires a successful interaction between knowledge, systems, and people.

Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.

We offer digital services on a scale that is unique in the industry, including visual support with augmented reality, remote diagnosis via QR code, and visual spare parts search.